GLA announces its RFP for 2017-18: click here for details. Applications will be accepted from June 15, 2017 to September 15, 2017 by online submission. Proposals will be reviewed, and funding decisions will be announced, in December 2017.
Grants are reviewed by the Grant Review Committee (GRC) of the Scientific Advisory Board (SAB), composed of experts in the tick-borne diseases research field. The Financial Review Committee (FRC) is available to advise in the event of any conflicts of interest or for commercial applications. Applications are reviewed by GLA to assure completion before review by the SAB.
Eligibility and description of grants program is available in the Research Grant Award information.
Once the entire grant review process is completed, the committee meets to discuss and prioritize the grant application award list in conjunction with the monies available, as assigned by GLA’s Executive Committee. The GRC makes its recommendations to the GLA Board of Directors, who make final decisions following majority approval of these recommendations.
All grant recipients are required to sign a Research Grant Agreement, created to protect both the grant recipient(s) and GLA. These agreements are tailored to each individual grant and are subject to negotiation. Monies are only awarded to a medical institution, foundation, or university, never to an individual. GLA accepts up to 10% indirect costs.